Focally regulated endothelial proliferation and cell death in human synovium

American Journal of Pathology

Volumn 152, Issue 3, 1998, Pages 691-702

  Walsh, David Andrew ^a,b   Wade, Mark ^a   Mapp, Paul Ian ^a   Blake, David Russel ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLINE; DEOXYRIBONUCLEOTIDE; INTEGRIN; KI 67 ANTIGEN; METHOTREXATE; PENICILLAMINE; PREDNISOLONE; SALAZOSULFAPYRIDINE; TERMINAL URIDYL DEOXYNUCLEOTIDE; THROMBOSPONDIN; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CELL DEATH; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; OSTEOARTHRITIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNOVITIS; SYNOVIUM;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; APOPTOSIS; ARTHRITIS, RHEUMATOID; CELL DIVISION; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; LYMPHOKINES; MALE; MIDDLE AGED; OSTEOARTHRITIS; PROLIFERATING CELL NUCLEAR ANTIGEN; RATS; RECEPTORS, VITRONECTIN; SYNOVIAL MEMBRANE; THROMBOSPONDINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0031913045     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (70)

1. Knight AD, Levick JR: The density and distribution of capillaries around the synovial cavity. Q J Exp Physiol 1983, 68:629-644
2. Lalor PA, Mapp PI, Hall PA, Revell PA: Proliferative activity of cells in the synovium as demonstrated by a monoclonal antibody, Ki67. Rheumatol Int 1987, 7:183-186
3. Wells AF, Klareskog L, Lindblad S, Laurent TC: Correlation between increased hyaluronan localized in arthritic synovium and the presence of proliferating cells: a role for macrophage-derived factors. Arthritis Rheum 1992, 35:391-396
4. Qu Z, Hernandez Garcia C, O'Rourke LM, Planck SR, Kohli M, Rosenbaum JT: Local proliferation of synoviocytes contributes to synovial hyperplasia. Arthritis Rheum 1994, 37:212-220
5. Folkman J, Klagsbrun M: Angiogenic factors. Science 1987, 235:442-447
6. Sholley MM, Ferguson GP, Seibel HR, Montour JL, Wilson JD: Mechanisms of neovascularisation: vascular sprouting can occur without proliferation of endothelial cells. Lab Invest 1984, 51:624-634
7. Mohr W, Beneke G, Mohing W: Proliferation of synovial lining cells and fibroblasts. Ann Rheum Dis 1975, 34:219-224
8. Nagashima M, Yoshino S, Ishiwata T, Asano G: Role of vascular endothelial growth factor in angiogenesis of rheumatoid arthritis. J Rheumatol 1995, 22:1624-1630
9. Lund-Oleson K: Oxygen tensions in synovial fluids. Arthritis Rheum 1970, 13:769-776
10. Goetzl EJ, Falchuk KH, Zeiger LS, Sullivan AL, Hebert CL, Adams JP, Decker JL: A physiological approach to the assessment of disease activity in rheumatoid arthritis. J Clin Invest 1971, 50:1167-1180
11. Naughton D, Whelan M, Smith EC, Williams R, Blake DR, Grootveld M: An investigation of the abnormal metabolic status of synovial fluid from patients with rheumatoid arthritis by high field proton nuclear magnetic resonance spectroscopy. FEBS Letts 1993, 317:135-138
12. Stevens CR, Blake DR, Merry P, Revell PA, Levick JR: Comparative study by morphometry of the microvasculature in normal and rheumatoid synovium. Arthritis Rheum 1991, 34:1508-1513
13. Čeponis A, Konttinen Y, Mackevičius Z, Solovieva SA, Hukkanen M, Tamulaitienè M, Matulis A, Santavirta S: Aberrant vascularity and von Willebrand factor distribution in inflamed synovial membrane. J Rheumatol 1996, 23:1880-1886
14. Desmouliere A, Redard M, Darby I, Gabbiani G: Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. Am J Pathol 1995, 146:56-66
15. Lang R, Lustig M, Francois F, Sellinger M, Plesken H: Apoptosis during macrophage-dependent ocular tissue remodelling. Development 1994, 120:3395-3403
16. Modlich U, Kaup FJ, Augustin HG: Cyclic angiogenesis and blood vessel regression in the ovary: blood vessel regression during luteolysis involves endothelial cell detachment and vessel occlusion. Lab Invest 1996, 74:771-780
17. Nakajima T, Aono H, Hasunuma T, Yamamoto K, Shirai T, Hirohata K, Nishioka K: Apoptosis and functional Fas antigen in rheumatoid arthritis synoviocytes. Arthritis Rheum 1995, 38:485-491
18. Fava RA, Olsen NJ, Spencer-Green G, Yeo KT, Yeo TK, Berse B, Jackman RW, Senger DR, Dvorak HF, Brown LF: Vascular permeability factor/endothelial growth factor (VPF/VEGF): accumulation and expression in human synovial fluids and rheumatoid synovial tissue. J Exp Med 1994, 180:341-346
19. Koch AE, Harlow LA, Haines GK, Amento EP, Unemori EN, Wong WL, Pope RM, Ferrara N: Vascular endothelial growth factor: a cytokine modulating endothelial function in rheumatoid arthritis. J Immunol 1994, 152:4149-4156
20. Koch AE, Friedman J, Burrows JC, Haines GK, Bouck NP: Localization of the angiogenesis inhibitor thrombospondin in human synovial tissues. Pathobiology 1993, 61:1-6
21. Matthias LJ, Gotis-Graham I, Underwood PA, McNeil HP, Hogg PJ: Identification of monoclonal antibodies that recognize different disulfide bonded forms of thrombospondin 1. Biochim Biophys Acta 1996, 1296:138-144
22. Plohet J, Schilling J, Gospodarowicz D: Isolation and characterization of a newly identified endothelial cell mitogen produced by AtT20 cells. EMBO J 1989, 8:3801-3807
23. 3 antagonists promote tumour regression by inducing apoptosis of angiogenic blood vessels. Cell 1994, 79:1157-1164
24. Alon T, Hemo I, Itin A, Pe'er J, Stone J, Keshet E: Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat Med 1995, 1:1024-1028
25. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA Jr, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988, 31:315-324
26. Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, Christy W, Cooke TD, Greenwald R, Hochberg M, Howell D, Kaplan D, Koopman W, Longley S III, Mankin H, McShane DJ, Medsger T Jr, Meenan R, Mikkelsen W, Moskowitz R, Murphy W, Rothschild B, Segal M, Sokoloff L, Wolfe F: Development of criteria for the classification and reporting of osteoarthritis: classification of osteoarthritis of the knee. Arthritis Rheum 1986, 29:1039-1049
27. Waseem NH, Lane DP: Monoclonal antibody analysis of the proliferating cell nuclear antigen (PCNA): structural conservation and the detection of a nucleolar form. J Cell Sci 1990, 96:121-129
28. Gerdes J, Schwab U, Lemke H, Stein H: Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 1983, 31:13-20
29. Schlingemann RO, Rietveld FJ, de Waal RM, Bradley NJ, Skene AI, Davies AJ, Greaves MF, Denekamp J, Ruiter DJ: Leukocyte antigen CD34 is expressed by a subset of cultured endothelial cells and on endothelial abluminal microprocesses in the tumor stroma. Lab Invest 1990, 62:690-696
30. Holthofer H: Lectin binding sites in kidney: a comparative study of 14 animal species. J Histochem Cytochem 1983, 31:531-537
31. Cheresh DA: Human endothelial cells synthesize and express and Arg-Gly-Asp directed adhesion receptor involved in attachment to fibrinogen and von Willebrand factor. Proc Natl Acad Sci USA 1987, 84:6471-6475
32. Davies J, Warwick J, Totty N, Philp R, Helfrich M, Horton M: The osteoclast functional antigen, implicated in the regulation of bone resorption, is biochemically related to the vitronectin receptor. J Cell Biol 1989, 109:1817-1826
33. Vinores SA, Khchle M, Mahlow J, Chiu C, Green WR, Campochiaro PA: Blood-ocular barrier breakdown in eyes with ocular melanoma. Am J Pathol 1995, 147:1289-1297
34. Clezardin P, McGregor JL, Lyon M, Clemetson KJ, Huppert J: Characterization of two murine monoclonal antibodies(P10, P12) directed against different determinants on human blood platelet thrombospondin. Eur J Biochem 1986, 154:95-102
35. Kuhn C, Mason RJ: Immunolocalization of SPARC, tenascin, and thrombospondin in pulmonary fibrosis. Am J Pathol 1995, 147:1759-1769
36. Shu S, Ju G, Fan L: The glucose oxidase-DAB-nickel method in peroxidase histochemistry of the nervous system. Neurosci Lett 1988, 85:169-171
37. Sanna PP, Jirikowski GF, Lewandowski GA, Bloom FE: Applications of DAPI cytochemistry to neurobiology. Biotech Histochem 1992, 67: 346-350
38. Gavrieli Y, Sherman Y, Ben-Sasson SA: Identification of programmed cell death in situ via specific labeling of nuclear fragmentation. J Cell Biol 1992, 119:493-501
39. Firestein GS, Yeo M, Zvaifler NJ: Apoptosis in rheumatoid synovium. J Clin Invest 1995, 96:1631-1638
40. Sugiyama M, Tsukazaki T, Yonekura A, Matsuzaki S, Yamashita S, Iwasaki K: Localisation of apoptosis and expression of apoptosis related proteins in the synovium of patients with rheumatoid arthritis. Ann Rheum Dis 1996, 55:442-449
41. 3 for angiogenesis. Science 1994, 264:569-571
42. Athanasou NA, Quinn J, Horton MA, McGee JO'D: New sites of cellular vitronectin receptor immunoreactivity detected with osteoclast-reacting monoclonal antibodies 13C2 and 23C6. Bone Miner 1990, 8:7-22
43. Brown LF, Yeo K-T, Berse B, Yeo T-K, Senger DR, Dvorak HF, Van De Water L: Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing. J Exp Med 1992, 176:1375-1379
44. Wight TN, Raugi GJ, Mumby SM, Bornstein P: Light microscopic immunolocation of thrombospondin in human tissues. J Histochem Cytochem 1985, 33:295-302
45. Zeymer U, Fishbein MC, Forrester JS, Cercek B: Proliferating cell nuclear antigen immunohistochemistry in rat aorta after balloon denudation; comparison with thymidine and bromodeoxyuridine labeling. Am J Pathol 1992, 141:685-690
46. Kamel OW, Franklin WA, Ringus JC, Meyer JS: Thymidine labeling index and Ki67 growth fraction in lesions of the breast. Am J Pathol 1989, 134:107-113
47. Vartanian RK, Weidner N: Correlation of intratumoral endothelial-cell proliferation with microvessel density (tumor angiogenesis) and tumor-cell proliferation in breast carcinoma. Am J Pathol 1994, 144: 1188-1194
48. Walsh DA, Hu D-E, Mapp PI, Polak JM, Blake DR, Fan T-PD: Substance P, and new vessel formation in the rat subcutaneous sponge granuloma. Histochem J 1996, 28:759-769
49. Gorczyca W, Bigman K, Mittelmann A, Ahmed T, Gong J, Melamed MR, Darzynkiewicz Z: Induction of DNA strand breaks associated with apoptosis during treatment of leukaemias. Leukemia 1993, 7:659-670
50. Gold R, Schmied M, Giegrich G, Breitschopf H, Hartung HP, Toyka KV, Lassmann H: Differentiation between cellular apoptosis and necrosis by combined use of in situ tailing and nick translation techniques. Lab Invest 1994, 71:219-225
51. Grasl-Kraupp B, Ruttkay-Nedecky B, Koudelka H, Bukowska K, Bursch W, Schulte-Hermann R: In situ detection of fragmented DNA (TUNEL assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: a cautionary note. Hepatology 1995, 21:1465-1468
52. Weidner N, Semple JP, Welch WR, Folkman J: Tumour angiogenesis and metastasis- correlation in invasive breast carcinoma. N Engl J Med 1991, 324:1-8
53. Maeda K, Chung YS, Takasuka S, Ogawa Y, Onoda N, Sawada T, Kato Y, Nitta A, Arimoto Y, Kondo Y: Tumour angiogenesis and tumour cell proliferation as prognostic indicators in gastric carcinoma. Br J Cancer 1995, 72:319-323
54. FitzGerald O, Soden M, Yanni G, Robinson R, Bresnihan B: Morphometric analysis of blood vessels in synovial membranes obtained from clinically affected and unaffected knee joints of patients with rheumatoid arthritis. Ann Rheum Dis 1991, 50:792-796
55. Shai SY, Fishel RS, Martin BM, Berk BC, Bernstein KE: Bovine angiotensin converting enzyme cDNA cloning and regulation. Increased expression during endothelial cell growth arrest. Circ Res 1992, 70:1274-1281
56. Rastinejad F, Polverini PJ, Bouck NP: Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene. Cell 1989, 56:345-355
57. Johnson BA, Haines GK, Harlow LA, Koch AE: Adhesion molecule expression in human synovial tissue. Arthritis Rheum 1993, 36:137-146
58. Wong SY, Purdie AT, Han P: Thrombospondin and other possible related matrix proteins in malignant and benign breast disease. Am J Pathol 1992, 140:1473-1482
59. McGregor B, Colon S, Mutin M, Chignier E, Zech P, McGregor J: Thrombospondin in human glomerulopathies; a marker of inflammation and early fibrosis. Am J Pathol 1994, 144:1281-1287
60. DiPietro LA: Thrombospondin as a regulator of angiogenesis. Regulation of Angiogenesis. Edited by ID Goldberg, EM Rosen. Basel, Birkhäuser Verlag, 1997, pp 295-314
61. Robaye B, Dumont JE: Phospholipase A2 activity is not involved in the tumor necrosis factor-triggered apoptotic DNA fragmentation in bovine aortic endothelial cells. Biochem Biophys Res Commun 1992, 188:1312-1317
62. Chu CQ, Field M, Feldmann M, Maini RN: Localization of tumor necrosis factor α in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis. Arthritis Rheum 1991, 34:1125-1132
63. Takeuchi M, Otsuka T, Matsui N, Asai K, Hirano T, Moriyama A, Isobe I, Eksioglu YZ, Matsukawa K, Kato T, Tada T: Aberrant production of gliostatin/platelet-derived endothelial cell growth factor in rheumatoid synovium. Arthritis Rheum 1994, 37:662-672
64. Qu Z, Huang XN, Ahmadi P, Andresevic J, Planck SR, Hart CE, Rosenbaum JT: Expression of basic fibroblast growth factor in synovial tissue from patients with rheumatoid arthritis and degenerative joint disease. Lab Invest 1995, 73:339-346
65. Harris ED Jr: Recent insights into the pathogenesis of the proliferative lesion in rheumatoid arthritis. Arthritis Rheum 1976, 19:68-72
66. Walsh DA, Mapp PI, Wharton J, Polak JM, Blake DR: Neuropeptide degrading enzymes in normal and inflamed human synovium. Am J Pathol 1993, 142:1610-1621
67. Peacock DJ, Banquerigo ML, Brahn E: Angiogenesis inhibition suppresses collagen arthritis. J Exp Med 1992, 175:1135-1138
68. Peacock DJ, Banquerigo ML, Brahn E: A novel angiogenesis inhibitor suppresses rat adjuvant arthritis. Cell Immunol 1995, 160:178-184
69. Levick JR: Hypoxia and acidosis in chronic inflammatory arthritis; relation to vascular supply and dynamic effusion pressure. J Rheumatol 1990, 17:579-582
70. Shweiki D, Itin A, Soffer D, Keshet E: Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-induced angiogenesis. Nature 1992, 359:843-845